Literature DB >> 1723370

Do calcium antagonists have a place in the treatment of mood disorders?

C Höschl1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1723370     DOI： 10.2165/00003495-199142050-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  67 in total

Review 1.  Multiple calcium channels and neuronal function.

Authors:  R J Miller
Journal:  Science       Date:  1987-01-02       Impact factor: 47.728

2.  Calcium channels in rat brain synaptosomes: identification and pharmacological characterization. High affinity blockade by organic Ca2+ channel blockers.

Authors:  T J Turner; S M Goldin
Journal:  J Neurosci       Date:  1985-03       Impact factor: 6.167

3.  Use of calcitonin in psychotic agitation or mania.

Authors:  J S Carman; R J Wyatt
Journal:  Arch Gen Psychiatry       Date:  1979-01

4.  Nimodipine, a new calcium antagonist, in the prophylactic treatment of migraine.

Authors:  H J Gelmers
Journal:  Headache       Date:  1983-05       Impact factor: 5.887

5.  Effectiveness of verapamil in the treatment of a manic patient.

Authors:  S L Dubovsky; R D Franks; M Lifschitz; P Coen
Journal:  Am J Psychiatry       Date:  1982-04       Impact factor: 18.112

6.  Oral nimodipine reduces prostaglandin and thromboxane production by arteries chronically exposed to a periarterial haematoma and the antifibrinolytic agent tranexamic acid.

Authors:  J D Pickard; V Walker; J Vile; S Perry; P J Smythe; R Hunt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

7.  Verapamil as maintenance treatment in bipolar illness: a case report.

Authors:  M J Gitlin; J Weiss
Journal:  J Clin Psychopharmacol       Date:  1984-12       Impact factor: 3.153

8.  Verapamil in affective disorders: a controlled, double-blind study.

Authors:  C Höschl; J Kozený
Journal:  Biol Psychiatry       Date:  1989-01-15       Impact factor: 13.382

9.  [Treatment of mania by a calcium inhibitor. Preliminary study].

Authors:  V Caillard; G Massé
Journal:  Encephale       Date:  1982       Impact factor: 1.291

10.  Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine.

Authors:  C Chouza; A Scaramelli; J L Caamaño; O De Medina; R Aljanati; S Romero
Journal:  Lancet       Date:  1986-06-07       Impact factor: 79.321
View more
  6 in total

Review 1.  Psychopharmacological properties of calcium channel inhibitors.

Authors:  O Pucilowski
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Hippocampal damage mediated by corticosteroids--a neuropsychiatric research challenge.

Authors:  C Höschl; T Hajek
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2001       Impact factor: 5.270

3.  Verapamil attenuates scopolamine induced cognitive deficits by averting oxidative stress and mitochondrial injury - A potential therapeutic agent for Alzheimer's Disease.

Authors:  Saravanaraman Ponne; Chinnadurai Raj Kumar; Rathanam Boopathy
Journal:  Metab Brain Dis       Date:  2019-11-05       Impact factor: 3.584

4.  Diltiazem as augmentation therapy in patients with treatment-resistant bipolar disorder: a retrospective study.

Authors:  P H Silverstone; L Birkett
Journal:  J Psychiatry Neurosci       Date:  2000-05       Impact factor: 6.186

Review 5.  Drug-induced depression. Incidence, avoidance and management.

Authors:  S B Patten; E J Love
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

Review 6.  Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression.

Authors:  D H Overstreet; O Pucilowski; A H Rezvani; D S Janowsky
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.